Rotavirus Gastroenteritis Clinical Trial
Official title:
A Phase II Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Subunit Rotavirus Vaccine in Healthy Infants Aged 6-12 Weeks and Healthy Toddlers Aged 7-71 Months
The purpose of this study is to assess the immunogenicity, safety and immune persistence of recombinant trivalent rotavirus subunit vaccine in healthy infants aged 6-12 weeks and healthy toddlers aged 7-71 months.
This clinical trial is aimed to evaluate the immunogenicity, safety and immune persistence of recombinant trivalent rotavirus subunit vaccine in Chinese healthy infants aged 6-12 weeks and healthy toddlers aged 7-71 months.The subjects will be divided into 12 subgroups. Two different immune regimens and two dose levels will be evaluated in each age group. Toddlers aged 7-71 months will receive two intramuscular injections on Day 0 and 28 or three intramuscular injections on Day 0, 28 and 56. Infants aged 6-12 weeks will receive three intramuscular injections on Day 0, 28 and 56 or Day 0, 56 and 112. Two dose (mid dose and high dose) will be included in each age group. To maintain blindness in the trial, in each age group with fixed immune regimen, subjects will be randomized in a 1:1:1 ratio to receive mid dose vaccine, high dose vaccine, or placebo. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01575197 -
Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana
|
Phase 4 | |
Completed |
NCT01202201 -
A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Japan
|
N/A | |
Completed |
NCT00953056 -
A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)
|
Phase 1 | |
Completed |
NCT00737503 -
Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab
|
Phase 4 | |
Completed |
NCT04185545 -
Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates
|
Phase 3 | |
Completed |
NCT03474055 -
Study on Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compare Non-Inferiority With ROTASIIL (Lyophilized BRV-PV) in Healthy Infants in India
|
Phase 2/Phase 3 | |
Completed |
NCT01236066 -
Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia
|
N/A | |
Completed |
NCT00489567 -
Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden
|
N/A | |
Completed |
NCT02584816 -
Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization
|
Phase 3 | |
Completed |
NCT02062385 -
Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)
|
Phase 3 | |
Completed |
NCT02133690 -
A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants
|
Phase 3 | |
Completed |
NCT01177657 -
Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil
|
N/A | |
Completed |
NCT00740935 -
Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.
|
Phase 4 | |
Completed |
NCT01265355 -
Community Based Prevention of Rotavirus Gastroenteritis by a Functional Food Supplement
|
Phase 2/Phase 3 | |
Completed |
NCT00169455 -
Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants
|
Phase 3 | |
Completed |
NCT04819412 -
To Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavirus
|
Phase 3 | |
Completed |
NCT02728869 -
Safety, Reactogenicity and Immunogenicity of Heat-stable Rotavirus Vaccine (HSRV) in Adults and Infants
|
Phase 1/Phase 2 | |
Recruiting |
NCT05958771 -
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
|
Phase 3 | |
Recruiting |
NCT01061658 -
Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine
|
Phase 1/Phase 2 | |
Completed |
NCT01508533 -
Epidemiology of Rotavirus Infection in North India Community
|
N/A |